Sakura, K.; Sasai, M.; Funaki, S.; Shintani, Y.; Okumura, M.; Kaneda, Y.
Add-On Effect of Hemagglutinating Virus of Japan Envelope Combined with Chemotherapy or Immune Checkpoint Inhibitor against Malignant Pleural Mesothelioma: An In Vivo Study. Cancers 2023, 15, 929.
https://doi.org/10.3390/cancers15030929
AMA Style
Sakura K, Sasai M, Funaki S, Shintani Y, Okumura M, Kaneda Y.
Add-On Effect of Hemagglutinating Virus of Japan Envelope Combined with Chemotherapy or Immune Checkpoint Inhibitor against Malignant Pleural Mesothelioma: An In Vivo Study. Cancers. 2023; 15(3):929.
https://doi.org/10.3390/cancers15030929
Chicago/Turabian Style
Sakura, Kazuma, Masao Sasai, Soichiro Funaki, Yasushi Shintani, Meinoshin Okumura, and Yasufumi Kaneda.
2023. "Add-On Effect of Hemagglutinating Virus of Japan Envelope Combined with Chemotherapy or Immune Checkpoint Inhibitor against Malignant Pleural Mesothelioma: An In Vivo Study" Cancers 15, no. 3: 929.
https://doi.org/10.3390/cancers15030929
APA Style
Sakura, K., Sasai, M., Funaki, S., Shintani, Y., Okumura, M., & Kaneda, Y.
(2023). Add-On Effect of Hemagglutinating Virus of Japan Envelope Combined with Chemotherapy or Immune Checkpoint Inhibitor against Malignant Pleural Mesothelioma: An In Vivo Study. Cancers, 15(3), 929.
https://doi.org/10.3390/cancers15030929